The combination of brain radiotherapy and chemoimmunotherapy “resulted in promising intracranial and systemic anti-tumor activity, with a manageable safety profile,” researchers wrote.

and specifically in the HER2-positive breast cancer brain metastasis, we observed that the presence of PIK3CA mutations, in fact, were linked to a worse prognosis. So a worse overall survival from ...

John Friend, MD, CEO of Kazia Therapeutics added, "The novelty of the science that Professor Rao has proposed with this dual combination of paxalisib and immunotherapy could advance the treatment of ...

Today, on World Cancer Day, we come together to raise awareness, promote early detection and encourage prevention.

Jan. 28, 2025 — A new study shows that asymptomatic brain metastasis is more ... responsible for 90 percent of cancer deaths. Researchers have found that the mutations driving it may stem ...

Jan. 15, 2025 — A new twist on a decades-old anticancer strategy has shown powerful effects against multiple cancer types in a preclinical study. The experimental approach, which uses tiny ...

In this video, Xiuning Le, MD, PhD, discusses the greatest areas of unmet need in the treatment of EGFR-mutated lung cancer.

Patients with BRAF V600E-mutated metastatic colorectal cancer experienced improved responses when treated with Braftovi plus Erbitux and mFOLFOX6.

The Rosalind study will bring together large numbers of 'super survivors', allowing scientists to explore why these patients ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

EMA committee recommends extension of marketing authorisation for Janssen-Cilag’s subcutaneous Rybrevant to treat advanced EGFR-mutated NSCLC: Beerse, Belgium Tuesday, February ...